US Stock MarketDetailed Quotes

WST West Pharmaceutical Services

Watchlist

297.570
-5.060-1.67%

Trading Aug 28 15:19 ET

21.59BMarket Cap42.33P/E (TTM)

West Pharmaceutical Services Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2.48%165M

-14.41%118.2M

7.24%776.4M

3.55%239M

36.23%230.1M

-2.25%169.2M

-8.66%138.1M

23.97%724M

43.53%230.8M

-11.15%168.9M

Net income from continuing operations

-28.24%111.3M

-17.64%115.3M

1.28%593.4M

33.01%137M

33.75%161.3M

-17.72%155.1M

-19.45%140M

-11.47%585.9M

-30.26%103M

-31.32%120.6M

Operating gains losses

----

-125.87%-5.2M

45.28%-16.8M

--0

--2.2M

--9.4M

2,612.50%20.1M

-1,946.67%-30.7M

--49.6M

Depreciation and amortization

14.08%38.9M

12.66%35.6M

13.85%137.3M

15.43%35.9M

19.80%35.7M

13.29%34.1M

6.76%31.6M

-1.39%120.6M

-9.59%31.1M

-0.67%29.8M

Deferred tax

----

221.75%37.5M

----

28.21%-30.8M

----

Other non cash items

33.90%-3.9M

43.08%-3.7M

-92.48%1M

-53.53%14.5M

82.54%-1.1M

-43.90%-5.9M

13.33%-6.5M

1,050.00%13.3M

82.46%31.2M

7.35%-6.3M

Change In working capital

155.73%14.1M

26.07%-34.6M

-36.00%-20.4M

-76.75%26.9M

177.02%24.8M

47.62%-25.3M

6.77%-46.8M

92.43%-15M

1,305.21%115.7M

-61.00%-32.2M

-Change in receivables

----

111.24%4M

----

71.17%-35.6M

----

-Change in inventory

----

72.89%-13.5M

----

42.43%-49.8M

----

-Change in payables and accrued expense

----

257.14%4.4M

----

-116.67%-2.8M

----

-Change in other current assets

----

-215.14%-21.3M

----

353.42%18.5M

----

-Change in other working capital

----

-89.03%6M

----

2,179.17%54.7M

----

Cash from discontinued investing activities

Operating cash flow

-2.48%165M

-14.41%118.2M

7.25%776.5M

3.60%239.1M

36.23%230.1M

-2.25%169.2M

-8.66%138.1M

23.97%724M

43.53%230.8M

-11.15%168.9M

Investing cash flow

Cash flow from continuing investing activities

-23.26%-101.2M

-10.35%-90.6M

-27.93%-368.7M

-14.77%-108.8M

-61.93%-95.7M

-24.39%-82.1M

-20.20%-82.1M

-13.87%-288.2M

-22.48%-94.8M

9.49%-59.1M

Capital expenditure reported

-32.89%-100.2M

-10.35%-90.6M

-27.20%-362M

-14.54%-108.7M

-65.74%-95.8M

-14.07%-75.4M

-24.77%-82.1M

-12.31%-284.6M

-24.05%-94.9M

11.49%-57.8M

Net business purchase and sale

----

--0

----

--0

----

Net other investing changes

----

-86.11%-6.7M

-200.00%-100K

107.69%100K

----

-244.00%-3.6M

-92.31%100K

---1.3M

Cash from discontinued investing activities

Investing cash flow

-23.26%-101.2M

-10.35%-90.6M

-27.93%-368.7M

-14.77%-108.8M

-61.93%-95.7M

-24.39%-82.1M

-20.20%-82.1M

-13.87%-288.2M

-22.48%-94.8M

9.49%-59.1M

Financing cash flow

Cash flow from continuing financing activities

-23.47%-218.3M

-281.69%-271M

-56.54%-459.6M

-1,894.74%-189.5M

70.35%-22.3M

-388.40%-176.8M

58.89%-71M

-74.66%-293.6M

-53.23%-9.5M

-1,196.55%-75.2M

Net issuance payments of debt

-4,580.00%-23.4M

0.00%-600K

94.81%-2.3M

0.00%-600K

98.59%-600K

0.00%-500K

0.00%-600K

-1,913.64%-44.3M

45.45%-600K

---42.6M

Net common stock issuance

-7.34%-187.2M

-280.45%-272.4M

-103.06%-451.2M

-177,200.00%-177.1M

-2.18%-28.1M

-503.46%-174.4M

56.84%-71.6M

-46.28%-222.2M

200.00%100K

-9,066.67%-27.5M

Cash dividends paid

-3.55%-14.6M

-4.26%-14.7M

-5.36%-57M

-4.96%-14.8M

-3.70%-14M

-7.63%-14.1M

-5.22%-14.1M

-5.87%-54.1M

-6.02%-14.1M

-7.14%-13.5M

Proceeds from stock option exercised by employees

-44.26%6.8M

9.80%16.8M

80.85%51M

-38.00%3.1M

142.86%20.4M

87.69%12.2M

84.34%15.3M

-23.99%28.2M

-39.76%5M

18.31%8.4M

Net other financing activities

----

---100K

91.67%-100K

----

---1.2M

--100K

--0

Cash from discontinued financing activities

Financing cash flow

-23.47%-218.3M

-281.69%-271M

-56.54%-459.6M

-1,894.74%-189.5M

70.35%-22.3M

-388.40%-176.8M

58.89%-71M

-74.66%-293.6M

-53.23%-9.5M

-1,196.55%-75.2M

Net cash flow

Beginning cash position

-32.10%601.8M

-4.52%853.9M

17.27%894.3M

23.26%898.6M

10.83%796.3M

32.74%886.3M

17.27%894.3M

23.90%762.6M

5.96%729M

24.70%718.5M

Current changes in cash

-72.24%-154.5M

-1,522.67%-243.4M

-136.43%-51.8M

-146.80%-59.2M

223.99%112.1M

-226.52%-89.7M

83.30%-15M

-12.65%142.2M

63.86%126.5M

-70.92%34.6M

Effect of exchange rate changes

-266.67%-1.1M

-224.29%-8.7M

208.57%11.4M

-62.63%14.5M

59.34%-9.8M

98.51%-300K

237.25%7M

33.12%-10.5M

1,592.31%38.8M

-234.72%-24.1M

End cash Position

-43.97%446.2M

-32.10%601.8M

-4.52%853.9M

23.26%898.6M

10.83%796.3M

32.74%886.3M

17.27%894.3M

5.96%729M

Free cash flow

-30.92%64.8M

-50.71%27.6M

-5.67%414.5M

-4.05%130.4M

20.88%134.3M

-12.34%93.8M

-34.43%56M

32.91%439.4M

61.21%135.9M

-10.98%111.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2.48%165M	-14.41%118.2M	7.24%776.4M	3.55%239M	36.23%230.1M	-2.25%169.2M	-8.66%138.1M	23.97%724M	43.53%230.8M	-11.15%168.9M
Net income from continuing operations	-28.24%111.3M	-17.64%115.3M	1.28%593.4M	33.01%137M	33.75%161.3M	-17.72%155.1M	-19.45%140M	-11.47%585.9M	-30.26%103M	-31.32%120.6M
Operating gains losses	----	----	-125.87%-5.2M	45.28%-16.8M	--0	--2.2M	--9.4M	2,612.50%20.1M	-1,946.67%-30.7M	--49.6M
Depreciation and amortization	14.08%38.9M	12.66%35.6M	13.85%137.3M	15.43%35.9M	19.80%35.7M	13.29%34.1M	6.76%31.6M	-1.39%120.6M	-9.59%31.1M	-0.67%29.8M
Deferred tax	----	----	221.75%37.5M	----	----	----	----	28.21%-30.8M	----	----
Other non cash items	33.90%-3.9M	43.08%-3.7M	-92.48%1M	-53.53%14.5M	82.54%-1.1M	-43.90%-5.9M	13.33%-6.5M	1,050.00%13.3M	82.46%31.2M	7.35%-6.3M
Change In working capital	155.73%14.1M	26.07%-34.6M	-36.00%-20.4M	-76.75%26.9M	177.02%24.8M	47.62%-25.3M	6.77%-46.8M	92.43%-15M	1,305.21%115.7M	-61.00%-32.2M
-Change in receivables	----	----	111.24%4M	----	----	----	----	71.17%-35.6M	----	----
-Change in inventory	----	----	72.89%-13.5M	----	----	----	----	42.43%-49.8M	----	----
-Change in payables and accrued expense	----	----	257.14%4.4M	----	----	----	----	-116.67%-2.8M	----	----
-Change in other current assets	----	----	-215.14%-21.3M	----	----	----	----	353.42%18.5M	----	----
-Change in other working capital	----	----	-89.03%6M	----	----	----	----	2,179.17%54.7M	----	----
Cash from discontinued investing activities
Operating cash flow	-2.48%165M	-14.41%118.2M	7.25%776.5M	3.60%239.1M	36.23%230.1M	-2.25%169.2M	-8.66%138.1M	23.97%724M	43.53%230.8M	-11.15%168.9M
Investing cash flow
Cash flow from continuing investing activities	-23.26%-101.2M	-10.35%-90.6M	-27.93%-368.7M	-14.77%-108.8M	-61.93%-95.7M	-24.39%-82.1M	-20.20%-82.1M	-13.87%-288.2M	-22.48%-94.8M	9.49%-59.1M
Capital expenditure reported	-32.89%-100.2M	-10.35%-90.6M	-27.20%-362M	-14.54%-108.7M	-65.74%-95.8M	-14.07%-75.4M	-24.77%-82.1M	-12.31%-284.6M	-24.05%-94.9M	11.49%-57.8M
Net business purchase and sale	----	----	--0	----	----	----	----	--0	----	----
Net other investing changes	----	----	-86.11%-6.7M	-200.00%-100K	107.69%100K	----	----	-244.00%-3.6M	-92.31%100K	---1.3M
Cash from discontinued investing activities
Investing cash flow	-23.26%-101.2M	-10.35%-90.6M	-27.93%-368.7M	-14.77%-108.8M	-61.93%-95.7M	-24.39%-82.1M	-20.20%-82.1M	-13.87%-288.2M	-22.48%-94.8M	9.49%-59.1M
Financing cash flow
Cash flow from continuing financing activities	-23.47%-218.3M	-281.69%-271M	-56.54%-459.6M	-1,894.74%-189.5M	70.35%-22.3M	-388.40%-176.8M	58.89%-71M	-74.66%-293.6M	-53.23%-9.5M	-1,196.55%-75.2M
Net issuance payments of debt	-4,580.00%-23.4M	0.00%-600K	94.81%-2.3M	0.00%-600K	98.59%-600K	0.00%-500K	0.00%-600K	-1,913.64%-44.3M	45.45%-600K	---42.6M
Net common stock issuance	-7.34%-187.2M	-280.45%-272.4M	-103.06%-451.2M	-177,200.00%-177.1M	-2.18%-28.1M	-503.46%-174.4M	56.84%-71.6M	-46.28%-222.2M	200.00%100K	-9,066.67%-27.5M
Cash dividends paid	-3.55%-14.6M	-4.26%-14.7M	-5.36%-57M	-4.96%-14.8M	-3.70%-14M	-7.63%-14.1M	-5.22%-14.1M	-5.87%-54.1M	-6.02%-14.1M	-7.14%-13.5M
Proceeds from stock option exercised by employees	-44.26%6.8M	9.80%16.8M	80.85%51M	-38.00%3.1M	142.86%20.4M	87.69%12.2M	84.34%15.3M	-23.99%28.2M	-39.76%5M	18.31%8.4M
Net other financing activities	----	---100K	91.67%-100K	----	----	----	----	---1.2M	--100K	--0
Cash from discontinued financing activities
Financing cash flow	-23.47%-218.3M	-281.69%-271M	-56.54%-459.6M	-1,894.74%-189.5M	70.35%-22.3M	-388.40%-176.8M	58.89%-71M	-74.66%-293.6M	-53.23%-9.5M	-1,196.55%-75.2M
Net cash flow
Beginning cash position	-32.10%601.8M	-4.52%853.9M	17.27%894.3M	23.26%898.6M	10.83%796.3M	32.74%886.3M	17.27%894.3M	23.90%762.6M	5.96%729M	24.70%718.5M
Current changes in cash	-72.24%-154.5M	-1,522.67%-243.4M	-136.43%-51.8M	-146.80%-59.2M	223.99%112.1M	-226.52%-89.7M	83.30%-15M	-12.65%142.2M	63.86%126.5M	-70.92%34.6M
Effect of exchange rate changes	-266.67%-1.1M	-224.29%-8.7M	208.57%11.4M	-62.63%14.5M	59.34%-9.8M	98.51%-300K	237.25%7M	33.12%-10.5M	1,592.31%38.8M	-234.72%-24.1M
End cash Position	-43.97%446.2M	-32.10%601.8M	-4.52%853.9M	-4.52%853.9M	23.26%898.6M	10.83%796.3M	32.74%886.3M	17.27%894.3M	17.27%894.3M	5.96%729M
Free cash flow	-30.92%64.8M	-50.71%27.6M	-5.67%414.5M	-4.05%130.4M	20.88%134.3M	-12.34%93.8M	-34.43%56M	32.91%439.4M	61.21%135.9M	-10.98%111.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall